The Department of Justice and the Department of Homeland Security subpoenaed the company for information related to its reporting of injuries, Peloton disclosed in an SEC filing on Friday. The company recalled its line of treadmills earlier this year after multiple reports of injuries and one death.
The company, which makes women's health drugs, said in an email that it had resolved the issue. The charges relate to alleged disclosures of nonpublic information to investment analysts in 2017 concerning interactions with the FDA.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
The company offers personalized 3-D printed clear aligners - essentially a form of transparent plastic braces - in a direct to consumer model that it touts as cheaper and more convenient than traditional options.
On the company's LunaDNA platform, a whole genome can be exchanged for 300 company shares, while 20 days of fitness data is equal to two shares.
The company, which will be listed on the Nasdaq exchange under the ticker symbol "LVGO," offers tech-enabled solutions that help to monitor and manage people with chronic conditions like diabetes, hypertension and behavioral health issues.
According to the company's prospectus, Phreesia's platform facilitated more than 54 million patient visits for approximately 50,000 individual providers and processed more than $1.4 billion in payments over the course of FY 2019.
Executives from Imagine360, Verily, BrightInsight, Lantern, and Rhapsody shared their approaches to reducing healthcare costs and facilitating digital transformation.
It was reported earlier this week in The Wall Street Journal that, while an IPO without the SEC signing off is allowed with a certain workaround, it is carries legal and regulatory risks.
The firm said both funds exceeded their initial targets. Versant plans to use Fund VII for at least 20 global biotech companies, while Versant Voyageurs I will be used to fund five to eight startups with Canadian operations.
The Boston-based company said it would not pursue a planned IPO, citing "market conditions." Nasdaq had agreed to its listing on Tuesday.
The London-based biotech would trade on the Nasdaq under the ticker symbol ORTX. The move comes two months after it closed a $150 million Series C and five months after it acquired a gene therapy portfolio from GSK.
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.
Frost, formerly Teva's chairman, is alleged in a lawsuit filed Friday to have taken part in a pump-and-dump operation that netted $27 million over five years.
The company, which has already raised more than $500 million in venture capital funding, would trade on the NASDAQ under the ticker symbol "GH."
The diagnostics company has cut back most of its staff from more than 100 employees to about two dozen in the wake of a civil fraud complaint from the SEC last month, according to The Wall Street Journal.
The SEC is also pursuing civil fraud charges against Ramesh “Sunny” Balwani, Theranos’s former president and chief operating officer.
It seems the biopharma industry isn't immune to the perils of "fake news." On Monday, the SEC publicized charges against 27 individuals and entities for alleged stock-promotion schemes on popular investor websites.